2005 Clinical Trials Treatment 
CannaMD
APRIL 23, 2020
For those unfamiliar, GB Sciences is a technology company that merges plant biology, cultivation, and post-production processes in order to optimize safe, consistent medical cannabis treatment. FDA in order to enter human clinical trial as early as this year! To learn more about GB Sciences, see: GBSciences.com.
Otherside Farms
JANUARY 23, 2019
Differential effects of repeated low dose treatment with the cannabinoid agonist WIN 55,212-2 in experimental models of bone cancer pain and neuropathic pain. The endogenous cannabinoid, anandamide, induces cell death in colorectal carcinoma cells: a possible role for cyclooxygenase 2 (full – 2005). abst – 2005).
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Cannigma
AUGUST 14, 2022
A 2005 study of terpenes found that pinene acts as an inhibitor of acetylcholinesterase, an enzyme that breaks down the neurotransmitter acetylcholine, which may help to enhance energizing and focus effects. But if you’re not a chronic user, consuming high amounts of THC can do more harm than help. Best terpenes for focus.
Cannabis Law Report
APRIL 8, 2022
This year, we are completing the second Phase 3 clinical trial of MDMA-assisted therapy for PTSD , the final stage prior to requesting FDA approval for a new prescription treatment to help heal trauma. For over three decades, we’ve been working to achieve mass mental health throughout the United States, Canada, and Europe.
Greencamp
FEBRUARY 2, 2019
Drugs used for the treatment of HIV and AIDS are called antiretroviral medications, and there are several different classes of these drugs: Fusion/Entry Inhibitors (they prevent, or more precisely slow down HIV from entering healthy cells). But I haven’t seen any clinical trials looking at the direct effects of THC on the virus.
Cannabis Law Report
JULY 12, 2019
Recent studies on the effectiveness of cannabidiol in the rare seizure disorders Dravet Syndrome and Lennox-Gastaut syndrome have prompted a biopharmaceutical company to perform clinical trials of its own to bring a cannabidiol based drug to the American market through the process of FDA approval. Medical Hypotheses (18 aug 2005).
Cannabis Law Report
NOVEMBER 24, 2021
It was also used as a topical treatment for haemorrhoids, ear infection, and wounds (Aldrich 1997 ; Touw 1981 ). The latter remains a dangerous drug and is considered higher risk for treatment than CBD (TGA 2019 ). 2005 ) and a more recent study that highlighted concerns from gastroenterologists in Australia (Benson et al.
Expert insights. Personalized for you.
116 
Let's personalize your content